<?xml version='1.0' encoding='UTF-8'?>
<DOC><DOCNO> WSJ871002-0167 </DOCNO><HL> Business Brief:Bristol-Myers Co.</HL><DD> 10/02/87</DD><SO> WALL STREET JOURNAL (J)</SO><IN> BMY AHPTENDER OFFERS, MERGERS, ACQUISITIONS (TNM) </IN><TEXT>   Bristol-Myers Co., New York, said it signed a letter of intent to sell its animal health care unit to American Home Products Corp., New York, for cash. The price wasn't disclosed.    Bristol-Myers Animal Health Care, Evansville, Ind., makes and distributes veterinary products. It has annual sales of $28 million to $30 million, an American Home official said. It is part of Bristol-Myers's U.S. pharmaceutical and nutritional group.    American Home, a maker of drugs and medical products, said the transaction would make it the third-largest supplier of veterinary health-care products, behind units of Merck andamp; Co., Rahway, N.J., and of SmithKline Beckman Corp., Philadelphia.    American Home has been interested in buying the unit for several years. Its complementary business, Fort Dodge Laboratories, sells animal-health vaccines and has annual sales of about $45 million.    In New York Stock Exchange composite trading yesterday, Bristol-Myers closed at $52.125 a share, up $1.625, while American Home closed at $86, up 37.5 cents. </TEXT></DOC>